| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/06/1994 | WO1994000458A1 N-substituted 3-azabicyclo[3.2.0]heptane derivates useful as neuroleptic agents, etc. |
| 01/06/1994 | WO1994000444A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 01/06/1994 | WO1994000437A1 Pharmaceutical pyridine compounds |
| 01/06/1994 | WO1994000434A1 Novel nicotinic acid esters |
| 01/06/1994 | WO1994000433A1 Process for making phenylthiomethylpyridinylalkenoates |
| 01/06/1994 | WO1994000431A1 N-substitued 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents etc. |
| 01/06/1994 | WO1994000419A1 Inhibitors of farnesyl protein transferase |
| 01/06/1994 | WO1994000148A1 Synthetic peptides for the treatment of myasthenia gravis |
| 01/06/1994 | WO1994000145A1 Targeted delivery of growth factors for bone regeneration |
| 01/06/1994 | WO1994000141A1 Glutathione as chemoprotective agent |
| 01/06/1994 | WO1994000140A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | WO1994000134A1 Preventing tissue adhesion using in situ modification of alginate |
| 01/06/1994 | WO1994000130A1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
| 01/06/1994 | WO1994000129A1 Use of phosphonates for the treatment of osteoporosis |
| 01/06/1994 | WO1994000128A1 ORAL 1α-HYDROXYPREVITAMIN D |
| 01/06/1994 | WO1994000120A1 Chemical compounds |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1993016701A3 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 01/06/1994 | WO1992009573A3 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/06/1994 | EP0583359A4 Method for treating hypothermia. |
| 01/06/1994 | CA2139323A1 Targeted delivery of growth factors for bone regeneration |
| 01/06/1994 | CA2139311A1 In situ modification of alginate |
| 01/06/1994 | CA2139136A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | CA2138992A1 Glutathione as chemoprotective agent |
| 01/06/1994 | CA2138955A1 Process for making phenylthiomethylpyridinylalkenoates |
| 01/06/1994 | CA2138954A1 Pharmaceutical pyridine compounds |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | CA2137455A1 Inhibitors of farnesyl protein transferase |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/05/1994 | EP0577470A1 2-Amino-N-[[[4-(aminocarbonyl)pyrimidin-2-yl]amino]alkyl]-pyrimidine-4-carboxamide derivates, their preparation and their use in therapeutics |
| 01/05/1994 | EP0577171A2 Use of piperazine acetamide derivatives against reperfusion damage |
| 01/05/1994 | EP0577151A1 Use of GHL-Cu as antiinflammatory agent |
| 01/05/1994 | EP0577024A1 3,4,5 substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
| 01/05/1994 | EP0577023A2 Angiotensin-II receptor-antagonists for the treatment of arrhythmices |
| 01/05/1994 | EP0576609A1 Receptors for bombesin-like peptides |
| 01/05/1994 | EP0576603A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 01/05/1994 | EP0576420A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it. |
| 01/05/1994 | DE4228493C1 Kurbeltrieb für einen Scheibenwischerantrieb eines Kraftfahrzeugs Crankshaft for a windshield wiper drive a motor vehicle |
| 01/05/1994 | CN1080172A Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 01/05/1994 | CN1080169A Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| 01/05/1994 | CN1023409C Production method of nutritive liquid |
| 01/05/1994 | CN1023402C Preparation of serotonin antagonists |
| 01/04/1994 | US5276153 Antagonist of platelet activating factor for bronchodilation |
| 01/04/1994 | US5276136 Laminin A chain polypeptides from the amino terminal globular domain |
| 01/04/1994 | US5276057 L-deprenyl for treating immune system dysfunction |
| 01/04/1994 | US5276044 Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions |
| 01/04/1994 | US5276043 Anabasine compounds |
| 01/04/1994 | US5276027 Ionotropic agents, vasodilation agents, circulation promoters, antiasthmetics, cognition activators, antidepressants and antiinflammatory agents |
| 01/04/1994 | US5276018 Composition comprising amino acids and methods for decreasing muscle breakdown |
| 01/04/1994 | US5276014 Human growth factor |
| 01/04/1994 | US5275826 Fluidized intestinal submucosa and its use as an injectable tissue graft |
| 01/04/1994 | US5275801 13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds, process for their production and pharmaceutical agents containing them |
| 01/04/1994 | CA2099556A1 2-amino-n-¬¬¬4-(aminocarbonyl)pyrimidin-2-yl|amino|alkyl| pyrimidine-4-carboxamide derivatives, preparation thereof and therapeutical application thereof |
| 01/04/1994 | CA1325809C Phenylene furyl, and thienyl leukotriene b_ analogues |
| 01/02/1994 | CA2099445A1 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 01/02/1994 | CA2099425A1 Angiotensin ii receptor antagonists for the treatment of disturbances in cardiac rhythm |
| 01/02/1994 | CA2095487A1 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
| 12/29/1993 | EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0575974A1 Use of 24,25-dihydroxyvitamin D3 for the manufacture of a medicament for the treatment of rickets |
| 12/29/1993 | EP0575844A2 Hydroxamic acid derivatives and pharmaceutical compositions thereof |
| 12/29/1993 | EP0575754A1 Pyridyl-1,2,5-oxadiazol-2-oxide-carbonamides for the treatment of NO-dependent disfunctions like angina pectoris and erection disorders |
| 12/29/1993 | EP0575614A1 Thiazole derivatives |
| 12/29/1993 | EP0575559A1 TGF-$g(b)1/$g(b)2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 12/29/1993 | EP0575556A1 Palytoxin-related prodrugs and a method for their administration |
| 12/29/1993 | EP0575555A1 Protein-induced morphogenesis |
| 12/29/1993 | EP0575500A1 Hiv protease inhibitors |
| 12/29/1993 | EP0575484A1 Method for promoting tissue repair and regeneration |
| 12/29/1993 | EP0575464A1 Modified factor vii |
| 12/29/1993 | EP0575454A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof. |
| 12/29/1993 | EP0575339A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 12/29/1993 | EP0575321A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
| 12/29/1993 | EP0314690B1 Sigma brain receptor ligands and their use |
| 12/29/1993 | CN1079954A Novel compound |
| 12/28/1993 | US5274104 N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders |
| 12/28/1993 | US5273995 [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]- 1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 12/28/1993 | US5273984 Salts formed between basic histamine H2 -receptor antagonists and bismuth complexes |
| 12/28/1993 | US5273977 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 12/28/1993 | US5273974 Condensed heterocyclic compounds, their production and use |
| 12/28/1993 | US5273747 Commiphora mukul extracts and therapeutical applications thereof |
| 12/28/1993 | CA1325695C Peptides with pharmaceutical activity |
| 12/28/1993 | CA1325598C Cosmetic composition |
| 12/28/1993 | CA1325595C Lubricant composition containing phospholipid and hyaluronic acid |
| 12/28/1993 | CA1325593C Composition of matter for increasing intracellular atp levels and physical performance levels and for increasing the rate of wound repair |
| 12/27/1993 | CA2099078A1 Imidazolyl-substituted cyclohexane derivatives |
| 12/27/1993 | CA2099068A1 Imidazolyl-substituted phenylpropionic and cinnamic acid derivatives |
| 12/26/1993 | CA2098166A1 Hydroxamic acid derivatives |
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025582A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
| 12/23/1993 | WO1993025576A2 Peptides having platelet-derived growth factor (pdgf) activity |
| 12/23/1993 | WO1993025547A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 12/23/1993 | WO1993025539A1 Novel piperzinyl-bis(alkylamino)pyrimidine derivatives and process for preparing same |
| 12/23/1993 | WO1993025517A1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 12/23/1993 | WO1993025246A1 Prosthetic devices having enhanced osteogenic properties |
| 12/23/1993 | WO1993025240A2 Pretargeting methods and compounds |
| 12/23/1993 | WO1993025227A1 Use of growth factor igf-ii |
| 12/23/1993 | WO1993025222A1 Stabilized somatotropin for parenteral administration |
| 12/23/1993 | WO1993025219A1 Prevention and treatment of peripheral neuropathy |
| 12/23/1993 | DE4243287A1 N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use |
| 12/23/1993 | DE4219973A1 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use |
| 12/23/1993 | CA2137684A1 Novel piperazinyl-bis(alkylamino)-pyrimidine derivatives and process for preparing same |